BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20716171)

  • 1. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
    Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
    Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
    Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
    J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.
    Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC
    Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
    Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
    Zhang J; Huang K; O'Neill KL; Pang X; Luo X
    Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
    Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
    BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
    Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
    J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interconnected hierarchical model of cell death regulation by the BCL-2 family.
    Chen HC; Kanai M; Inoue-Yamauchi A; Tu HC; Huang Y; Ren D; Kim H; Takeda S; Reyna DE; Chan PM; Ganesan YT; Liao CP; Gavathiotis E; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2015 Oct; 17(10):1270-81. PubMed ID: 26344567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
    Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
    Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program.
    Ren D; Tu HC; Kim H; Wang GX; Bean GR; Takeuchi O; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Science; 2010 Dec; 330(6009):1390-3. PubMed ID: 21127253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upgrading the BCL-2 network.
    Galonek HL; Hardwick JM
    Nat Cell Biol; 2006 Dec; 8(12):1317-9. PubMed ID: 17139279
    [No Abstract]   [Full Text] [Related]  

  • 12. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
    Gillespie S; Borrow J; Zhang XD; Hersey P
    Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas.
    Bai M; Papoudou-Bai A; Horianopoulos N; Grepi C; Agnantis NJ; Kanavaros P
    Hum Pathol; 2007 Jan; 38(1):103-13. PubMed ID: 16949642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bcl-2 family members in malignant pleural mesothelioma.
    O'Kane SL; Pound RJ; Campbell A; Chaudhuri N; Lind MJ; Cawkwell L
    Acta Oncol; 2006; 45(4):449-53. PubMed ID: 16760181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
    Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
    Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim.
    Jabbour AM; Heraud JE; Daunt CP; Kaufmann T; Sandow J; O'Reilly LA; Callus BA; Lopez A; Strasser A; Vaux DL; Ekert PG
    Cell Death Differ; 2009 Apr; 16(4):555-63. PubMed ID: 19079139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.
    Sinicrope FA; Rego RL; Okumura K; Foster NR; O'Connell MJ; Sargent DJ; Windschitl HE
    Clin Cancer Res; 2008 Sep; 14(18):5810-8. PubMed ID: 18794091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation.
    Vela L; Gonzalo O; Naval J; Marzo I
    J Biol Chem; 2013 Feb; 288(7):4935-46. PubMed ID: 23283967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
    Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
    J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of pro- and antiapoptotic molecules of the Bcl-2 family in human islets postisolation.
    Campbell PD; Weinberg A; Chee J; Mariana L; Ayala R; Hawthorne WJ; O'Connell PJ; Loudovaris T; Cowley MJ; Kay TW; Grey ST; Thomas HE
    Cell Transplant; 2012; 21(1):49-60. PubMed ID: 21535910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.